Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 71, 2016 - Issue 3
466
Views
11
CrossRef citations to date
0
Altmetric
Review

Cystinosis: a new perspective

, , , , &

References

  • Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med. 2002;347:111–21.
  • Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet. 1998;18:319–24.
  • Levtchenko E, Van den Heuvel L, Emma F, Antignac C. Clinical utility gene card for: cystinosis. Eur J Hum Genet. 2014;22(5).
  • Emma F, Nesterova G, Langman C, Labbé A, Cherqui S, Goodyer P, et al. Nephropathic cystinosis an international consensus document. Nephrol Dial Transplant. 2014;29:iv87–iv94.
  • Baum M. The Fanconi Syndrome of cystinosis: insights into the pathophysiology. Pediatr Nephrol. 1998;12:492–7.
  • Brodehl J, Hagge W, Gellissen K. Changes in kidney function in cystinosis. I. Inulin, PAH and electrolyte clearance in various stages of the disease. Ann Paediatr. 1965;205:131–54.
  • Levtchenko E, Monnens L. Development of Fanconi syndrome during infancy in a patient with cystinosis. Acta Paediatr. 2006;95:379–80.
  • Drube J, Schiffer E, Mischak H, Kemper MJ, Neuhaus T, Pape L, et al. Urinary proteome pattern in children with renal Fanconi Syndrome. Nephrol Dial Transplant. 2009;24(7):2161–9.
  • Wilmer MJ, Christensen EI, van den Heuvel LP, Monnens LA, Levtchenko EN. Urinary protein excretion pattern and renal expression of megalin and cubulin in neprhopathic cystinosis. Am J Kidney Dis. 2008;51:893–903.
  • Gahl WA. Cystinosis coming of age. Adv Pediatr. 1986;33:95–126.
  • Chik CL, Friedman A, Merriam GR, Gahl WA. Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med. 1993;119;568–75.
  • Besouw MT, Kremer JA, Janssen MC, Levtchenko EN. Fertility status in male cystinosis patients treated with cysteamine. Fertil Steril. 2010;93:1880–3.
  • Fivush B, Green OC, Porter CC, Balfe JW, O’Regan S, Gahl WA. Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child. 1987;141:1087–9.
  • Robert JJ, Tête MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M. Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol. 1999;13(6):524–9.
  • Winkler L, Offner G, Krull F, Brodehl J. Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr. 1993;152:244–9.
  • Gahl WA, Dalakas MC, Charnas L, Chen KT, Pezeshkpour GH, Kuwabara T, et al. Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis. N Engl J Med. 1988;319:1461–4.
  • Trauner DA, Fahmy RF, Mishler DA. Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. Pediatr Neurol. 2001;24:365–8.
  • Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Med (Baltimore). 2005;84:137–46.
  • Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, et al. Pulmonary dysfunction in adults with nephropathic cystinosis. Chest. 2001;119:394–401.
  • Langman CB, Moore ES, Thoene JG, Schneider JA. Renal failure in a sibship with late-onset cystinosis. J Pediatr. 1985;107:755–6.
  • Anikster Y, Lucero C, Guo J, Huizing M, Shotelersuk V, Bernardini I, et al. Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res. 2000;47:17–23.
  • Jackson M, Young E. Prenatal diagnosis of cystinosis by quantitative measurement of cystine in chorionic villi and cultured cells. Prenat Diagn. 2005;25:1045–7.
  • Wilmer MJ, Schoeber JP, van den Heuvel LP, Levtchenko EN. Cystinosis: practical tools for diagnosis and treatment. Pediatr Nephrol. 2011;26:205–15.
  • Nesterova G, Gahl W. Cystinosis: the evolution of a treatable disease. Pediatr Nephrol. 2013;28:51–9.
  • Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H. Comparison of cystine determination in mixed leucocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy. Clin Chem. 2004;50:1686–8.
  • Chabli A, Aupetit J, Rachm M, Ricquier D, Chadefaux-Vekemans B. Measurement of cystine in granulocytes using liquid chromatography-tandem mass spectrometry. Clin Biochem. 2007;40:692–8.
  • Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine therapy. N Engl J Med. 1993;328:1157–62.
  • Gahl WA, Balog JZ, Kleta R. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med. 2007;147:242–50.
  • Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int. 2011;81:179–89.
  • Van Stralen KJ, Emma F, Jager KJ, Verrina E, Schaefer F, Laube G, et al. Improvement in the renal prognosis in nephropathic cystinosis. Clin J Am Soc Nephrol. 2011;6:2485–91.
  • Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, et al. Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr. 2004;145:555–60.
  • Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987;316:971–7.
  • Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab. 1995;80:3257–61.
  • Levtchenko E, Blom H, Wilmer M, van den Heuvel L, Monnens L. ACE inhibitor enalapril diminishes albuminuria in patients with cystinosis. Clin Nephrol. 2003;60:386–9.
  • Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976;58:180–9.
  • Schneider JA, Clark KF, Greene AA, Reisch JS, Markello TC, Gahl WA, et al. Recent advances in the treatment of cystinosis. J Inherit Metab Dis. 1995;18:387–97.
  • Besouw MTP, Levtchenko Elena N. Improving the prognosis of nephropathic cystinosis. Int J Nephrol Renovasc Dis. 2014;7:297–302.
  • Middleton R, Bradbury M, Webb N, O’Donoghue D, van’t Hoff W. Cystinosis. A clinicopathological conference. ‘From toddlers to twenties and beyond’ Adult-Paediatric Nephrology Interface Meeting, Manchester 2001. Nephrol Dial Transplant. 2003;18:2492–5.
  • Besouw MT, Bowker R, Dutertre JP, Emma F, Gahl WA, Greco M, et al. Cysteamine toxicity in patients with cystinosis. J Pediatr. 2011;159;1004–11.
  • Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, et al. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis. Pediatr Nephrol. 2006;21:110–3.
  • Dohil M, Fidler M, Barshop BA, Gangoiti J, Deutsch R, Martin M, et al. Understanding intestinal cysteamine bitartrate absorption. J Pediatr. 2006;148:764–9.
  • Dohil R, Fidler M, Barshop B, Newbury R, Sellers Z, Deutsch R, et al. Esomeprazole therapy for gastric acid hypersecretion in children with Cystinosis. Pediatr Nephrol. 2005;12:56–98.
  • Besouw M, Blom H, Tangerman A, de Graaf-Hess A, Levtchenko E. The origin of halithosis in cystinotic patients due to cysteamine treatment. Mol Gen Metab. 2007;91:228–33.
  • Dohil R, Fidler M, Gangoiti JA, Kaskel F, Schneider JA, Barshop BA. Twice-daily Cysteamine Bitartrate Therapy for Children with Cystinosis. J Pediatr. 2010;156(1):71–5.
  • Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, et al. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: Effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol. 2012;7:1112–20.
  • Besouw M, Tangerman A, Cornelissen E, Rioux P, Levtchenko E. Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate. Mol Genet Metab. 2012;107:234–6.
  • Langman C, Rioux P, Greenbaum L, et al. Extended treatment of patients with cystinosis and CKD with RP103 demonstrates efficacy and safety. Pediatr Nephrol. 2013;28:1363.
  • Dohil R, Cabrera BL. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up. Pediatr Nephrol. 2013;28:507–10.
  • Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, et al. Quality of Life is improved and Kindey function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J Pediatr. 2014;165(3):528–33.
  • Doyle M, Werner-Lin A. That eagle covering me: transitioning and connected autonomy for emerging adults with cystinosis. Pediatr Nephrol. 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.